A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study

More than 85% of patients with T1 colorectal cancer have no lymph node metastasis and can be cured by endoscopic resection. To avoid unnecessary surgery after complete endoscopic resection, accurate histologic methods for evaluating resected specimens are needed to discriminate those at high risk for lymph node metastasis. A retrospective multi-institutional, cross-sectional study of 806 T1 colorectal cancer patients was conducted. A budding/sprouting score was incorporated for predicting lymph node metastasis in addition to other parameters, including the depth of submucosal invasion, histologic grade, and lymphovascular invasion. Lymph node metastasis was detected in 97 patients. Independent predictors of lymph node metastasis by multivariate analysis were depth of submucosal invasion ≥1000 μm (odds ratio (95% confidence interval)=5.56 (2.14–19.10)) and high-grade budding/sprouting (3.14 (1.91–5.21)). Among lesions with a depth of submucosal invasion ≥1000 μm, lymph node metastasis was detected in 59 (29%) of 207 patients with high-grade budding/sprouting, and in 34 (9%) of 396 with low-grade budding/sprouting. Lymph node metastasis was detected in only 4 (2%) of 203 lesions with a depth of submucosal invasion <1000 μm. Of these four tumors, three invaded lymphatic and/or venous vessels. Thus, the risk for lymph node metastasis can be classified into three groups: high risk with a depth of submucosal invasion ≥1000 μm and high-grade budding/sprouting, intermediate-risk with a depth of submucosal invasion ≥1000 μm and low-grade budding/sprouting, and low-risk with a depth of submucosal invasion <1000 μm. These findings revealed that a depth of submucosal invasion ≥1000 μm and high-grade budding/sprouting are powerful predictive parameters for lymph node metastasis in T1 colorectal cancer. This three-tier risk classification system will facilitate the decision for additional major surgery for T1 colorectal cancer patients after successful endoscopic treatment.

[1]  R. Haggitt,et al.  Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. , 1985, Gastroenterology.

[2]  Tadakazu Shimoda,et al.  Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma , 2010, Modern Pathology.

[3]  C. Dukes,et al.  The surgical treatment of malignant rectal polyps. , 1952, Lancet.

[4]  L. Burgart,et al.  Risk of Lymph Node Metastasis in T1 Carcinoma of the Colon and Rectum , 2002, Diseases of the colon and rectum.

[5]  H. Baba,et al.  The risk of lymph node metastasis in T1 colorectal carcinoma. , 2004, Hepato-gastroenterology.

[6]  K. Togashi,et al.  Predictive factors for lymph node metastasis in t1 stage colorectal Carcinomas , 2003, Diseases of the colon and rectum.

[7]  I. Hirata,et al.  Analysis of pathological risk factors for lymph node metastasis of submucosal invasive colon cancer , 2004, Modern Pathology.

[8]  K. Okita,et al.  Endoscopic therapy for early colon cancer: the strip biopsy resection technique. , 1991, Gastrointestinal endoscopy.

[9]  Tsutomu Yoshida,et al.  Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths , 2009, Scandinavian journal of gastroenterology.

[10]  K. Forde,et al.  Endoscopic Polypectomy: lnadequa te Treatment for lnvasive Colorectal Carcinoma , 1981, Annals of surgery.

[11]  T. Muto,et al.  Predictive value of histology at the invasive margin in the prognosis of early invasive colorectal carcinoma , 2000, Journal of Gastroenterology.

[12]  Toshihide Kumamoto,et al.  Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study , 2004, Journal of Gastroenterology.

[13]  S. Kudo,et al.  Endoscopic Mucosal Resection of Flat and Depressed Types of Early Colorectal Cancer , 1993, Endoscopy.

[14]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[15]  K. Hase,et al.  Prognostic value of tumor “budding” in patients with colorectal cancer , 1993, Diseases of the colon and rectum.

[16]  J. Guillem,et al.  Lymph node metastasis in T1 adenocarcinoma of the colon and rectum , 2004, Journal of Gastrointestinal Surgery.

[17]  C. Williams,et al.  Removal of Polyps with Fibreoptic Colonoscope: A New Approach to Colonic Polypectomy , 1973, British medical journal.

[18]  M. Zampino,et al.  Rectal cancer. , 2009, Critical reviews in oncology/hematology.

[19]  I. Nagtegaal,et al.  Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions , 2013, Endoscopy.

[20]  Seung-Yong Jeong,et al.  Indications for Subsequent Surgery After Endoscopic Resection of Submucosally Invasive Colorectal Carcinomas: A Prospective Cohort Study , 2009, Diseases of the colon and rectum.

[21]  S. Kitano,et al.  Risk Factors for Occult Lymph Node Metastasis of Colorectal Cancer Invading the Submucosa and Indications for Endoscopic Mucosal Resection , 2007, Diseases of the colon and rectum.

[22]  Tnm.  The tnm classification of malignant tumors , 1988 .

[23]  R. Labianca,et al.  Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  R. Riddell,et al.  Tumor budding in colorectal carcinoma: time to take notice , 2012, Modern Pathology.

[25]  K. Chayama,et al.  Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection , 2012, Journal of gastroenterology and hepatology.

[26]  Hidetaka Mochizuki,et al.  Risk factors for an adverse outcome in early invasive colorectal carcinoma. , 2004, Gastroenterology.

[27]  M. Morimatsu,et al.  An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer , 1989, Cancer.

[28]  A. Radcliffe,et al.  Systematic review and meta‐analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer , 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[29]  S. Ishiguro,et al.  New indication for endoscopic treatment of colorectal carcinoma with submucosal invasion , 2004, Journal of gastroenterology and hepatology.

[30]  B C Morson,et al.  Factors influencing the prognosis of early cancer of the rectum. , 1966, Proceedings of the Royal Society of Medicine.

[31]  富永 健司.  Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma , 2006 .

[32]  H. Ikematsu,et al.  Risk of lymph node metastasis in patients with pedunculated type early invasive colorectal cancer: A retrospective multicenter study , 2011, Cancer science.

[33]  J. Imura,et al.  Evaluation of Tumor Cell Dissociation as a Predictive Marker of Lymph Node Metastasis in Submucosal Invasive Colorectal Carcinoma , 2005, Diseases of the colon and rectum.

[34]  Y. Araki,et al.  Clinicopathological characteristics of colorectal submucosal carcinoma with lymph node metastasis. , 1993, The Kurume Medical Journal.